Hancock Whitney Corp Harmony Biosciences Holdings, Inc. Transaction History
Hancock Whitney Corp
- $3 Billion
- Q1 2025
A detailed history of Hancock Whitney Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 8,828 shares of HRMY stock, worth $313,217. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,828
Previous 8,768
0.68%
Holding current value
$313,217
Previous $301,000
2.66%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
283Shares Held
44.9MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$235 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$167 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$56 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$45.7 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...